Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Blood Rheology Solutions is a medical technology company specializing in the development of diagnostic tools for measuring the rheological properties of blood. Spun out from Swansea University, the company's core technology focuses on assessing blood viscosity and clotting characteristics, which are critical indicators in cardiovascular health and critical care. Their flagship product, the Hemorheograph, provides clinicians with real-time data on blood flow behavior to improve patient monitoring and treatment outcomes. The company aims to enhance point-of-care diagnostics for conditions such as sepsis, thrombosis, and hyperviscosity syndrome. By utilizing advanced sensors and fluid dynamics research, Blood Rheology Solutions offers a more precise alternative to traditional blood testing methods.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Blood Rheology Solutions.